AEArnold M. Epstein

Arnold M. Epstein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arnold M. Epstein has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Endel John Orav

    Division of General Internal Medicine and Primary Care (E.J.O., J.F.F.), Brigham and Women’s Hospital, Boston, MA

    3 shared publications
  • Eric C. Schneider

    Eric C. Schneider is senior vice president for policy and research at the Commonwealth Fund

    3 shared publications
  • Karen E. Joynt Maddox

    Washington University School of Medicine, St. Louis, Missouri

    3 shared publications
  • Ashish K. Jha

    From the Department of Health Policy and Management (A.M.E., K.E.J., A.K.J.) and Department of Biostatistics (E.J.O.), Harvard School of Public Health, Boston, MA; Department of Medicine, Division of General Medicine, (A.M.E., A.K.J., E.J.O.) and Division of Cardiovascular Medicine (K.E.J.), Brigham and Women’s Hospital, Boston, MA; and Department of Medicine, VA Boston Healthcare System, Boston, MA (K.E.J., A.K.J.).

    2 shared publications
  • E. John Orav

    From the Department of Health Policy and Management (A.M.E., K.E.J., A.K.J.) and Department of Biostatistics (E.J.O.), Harvard School of Public Health, Boston, MA; Department of Medicine, Division of General Medicine, (A.M.E., A.K.J., E.J.O.) and Division of Cardiovascular Medicine (K.E.J.), Brigham and Women’s Hospital, Boston, MA; and Department of Medicine, VA Boston Healthcare System, Boston, MA (K.E.J., A.K.J.).

    2 shared publications
  • Jie Zheng

    Department of Automation, Tsinghua University, Beijing, China

    2 shared publications

Latest Publications

  • Open Access

    Changes in Cardiovascular Spending, Care Utilization, and Clinical Outcomes Associated With Participation in Bundled Payments for Care Improvement – Advanced

    by Sukruth A. Shashikumar, Jie Zheng, E. John Orav, Arnold M. Epstein, Karen E. Joynt Maddox

    BACKGROUND: Bundled Payments for Care Improvement – Advanced (BPCI-A) is a Medicare initiative that aims to incentivize reductions in spending for episodes of care that start with a hospitalization and end 90 days after discharge. Cardiovascular disease, an important driver of Medicare spending, is one of the areas of focus BPCI-A. It is unknown whether BPCI-A is associated with spending reductions or quality improvements for the 3 cardiovascular medical events or 5 cardiovascular procedures in the model. METHODS: In this retrospective cohort study, we conducted difference-in-differences analyses using Medicare claims for patients discharged between January 1, 2017, and September 30, 2019, to assess differences between BPCI-A hospitals and matched nonparticipating control hospitals. Our primary outcomes were the differential changes in spending, before versus after implementation of BPCI-A, for cardiac medical and procedural conditions at BPCI-A hospitals compared with controls. Secondary outcomes included changes in patient complexity, care utilization, healthy days at home, readmissions, and mortality. RESULTS: Baseline spending for cardiac medical episodes at BPCI-A hospitals was $25 606. The differential change in spending for cardiac medical episodes at BPCI-A versus control hospitals was $16 (95% CI, −$228 to $261; P =0.90). Baseline spending for cardiac procedural episodes at BPCI-A hospitals was $37 961. The differential change in spending for cardiac procedural episodes was $171 (95% CI, −$429 to $772; P =0.58). There were minimal differential changes in physicians’ care patterns such as the complexity of treated patients or in their care utilization. At BPCI-A versus control hospitals, there were no significant differential changes in rates of 90-day readmissions (differential change, 0.27% [95% CI, −0.25% to 0.80%] for medical episodes; differential change, 0.31% [95% CI, −0.98% to 1.60%] for procedural episodes) or mortality (differential change, −0.14% [95% CI, −0.50% to 0.23%] for medical episodes; differential change, −0.36% [95% CI, −1.25% to 0.54%] for procedural episodes). CONCLUSIONS: Participation in BPCI-A was not associated with spending reductions, changes in care utilization, or quality improvements for the cardiovascular medical events or procedures offered in the model.


  • Medicare’s Bundled Payments For Care Improvement Advanced Model: Impact On High-Risk Beneficiaries

    by Karen E. Joynt Maddox, E. John Orav, Jie Zheng, Arnold M. Epstein

    Medicare’s Bundled Payments for Care Improvement Advanced Model (BPCI-A) is a voluntary Alternative Payment Model in which participating hospitals are held accountable for ninety-day episodes of care. To meet spending targets, hospitals must either decrease utilization or attract a less sick patient population; this could lead to the elimination of necessary care or avoidance of patients with medical or social vulnerability. We used publicly available data on BPCI-A participation, along with Medicare claims from the period 2017–19, to examine patient selection, changes in Medicare payment, and key clinical outcomes among three groups: patients with frailty, patients with multimorbidity, and patients with dual enrollment (both Medicare and Medicaid). We found no consistent change in patient selection associated with BPCI-A participation. Patients with frailty, multimorbidity, or dual enrollment were more expensive at baseline, but Medicare payments decreased similarly in these groups compared with lower-risk patients. There were no differential negative changes in clinical outcomes between BPCI-A participants and nonparticipants among patients with medical or social vulnerability.


  • Open Access

    Characteristics of Hospitals That Did and Did Not Join the Bundled Payments for Care Improvement–Advanced Program

    by Karen E. Joynt Maddox, E. John Orav, Jie Zheng, Arnold M. Epstein

    The Bundled Payments for Care Improvement (BPCI) initiative1 and its 2018 successor, BPCI-Advanced (BPCI-A), which continues through 2023, are central to the Centers for Medicare & Medicaid Services’ (CMS’) move toward value-based and alternative payment models.2 Under bundled payments, an accountable entity takes responsibility for the costs of an “episode” of care from hospitalization through 90 days after discharge.


  • Effect of a Hospital-wide Measure on the Readmissions Reduction Program

    by Rachael B. Zuckerman, Karen E. Joynt Maddox, Steven H. Sheingold, Lena M. Chen, Arnold M. Epstein

    The Hospital Readmissions Reduction Program penalizes hospitals that have high 30-day readmission rates across specific conditions. There is support for changing to a hospital-wide readmission measure to broaden hospital eligibility and provide incentives for improvement across more conditions.


  • Open Access

    Low-Income Residents In Three States View Medicaid As Equal To Or Better Than Private Coverage, Support Expansion

    by Arnold M. Epstein, Benjamin D. Sommers, Yelena Kuznetsov, Robert J. Blendon

    Expansion of Medicaid under the Affordable Care Act to millions of low-income adults has been controversial, yet little is known about what these Americans themselves think about Medicaid. We conducted a telephone survey in late 2013 of nearly 3,000 low-income adults in three Southern states—Arkansas, Kentucky, and Texas—that have adopted different approaches to the options for expansion. Nearly 80 percent of our sample in all three states favored Medicaid expansion, and approximately two-thirds of uninsured respondents said that they planned to apply for either Medicaid or subsidized private coverage in 2014. Yet awareness of their state’s actual expansion plans was low. Most viewed having Medicaid as better than being uninsured and at least as good as private insurance in overall quality and affordability. While the debate over Medicaid expansion continues, support for expansion is strong among low-income adults, and the perceived quality of Medicaid coverage is high.


    • 1 October 2014
      • Vol. 20  (10) , e479-86

    The impact of pay-for-performance on quality of care for minority patients.

    by Arnold M Epstein, Ashish K Jha, E John Orav

    To determine whether racial disparities in process quality and outcomes of care change under hospital pay-for-performance. Retrospective cohort study comparing the change in racial disparities in process quality and outcomes of care between 2004 and 2008 in hospitals participating in the Premier Hospital Quality Incentive Demonstration versus control hospitals. Using patient-level Hospital Quality Alliance (HQA) data, we identified 226,096 patients in Premier hospitals, which were subject to pay-for-performance (P4P) contracts and 1,607,575 patients at control hospitals who had process of care measured during hospitalization for acute myocardial infarction (AMI), congestive heart failure (CHF), or pneumonia. We additionally identified 123,241 Medicare patients in Premier hospitals and 995,107 in controls who were hospitalized for AMI, CHF, pneumonia, or coronary artery bypass graft (CABG) surgery. We then compared HQA process quality indicators for AMI, CHF, and pneumonia between P4P and control hospitals, as well as risk-adjusted mortality rates for AMI, CHF, pneumonia, and CABG. Black patients initially had lower performance on process quality indicators in both Premier and non-Premier hospitals. The racial gap decreased over time in both groups; the reduction in the gap in Premier hospitals was greater than the gap reduction in non-Premier hospitals for AMI patients. During the study period, mortality generally decreased for blacks relative to whites for AMI, CHF, and pneumonia in both Premier and non-Premier hospitals, with the relative reduction for blacks greatest in Premier hospitals for CHF. Our results show no evidence of a deleterious impact of P4P in the Premier HQID on racial disparities in process quality or outcomes.


  • Access to Coronary Artery Bypass Graft Surgery Under Pay for Performance

    by Arnold M. Epstein, Karen E. Joynt, Ashish K. Jha, E. John Orav, Kachalia A, Mello M, Nallamothu B, Studdert D, Joynt K

    Background—: Although pay for performance (P4P) has become common, many worry that P4P will lead providers to avoid offering surgical procedures to the sickest patients out of concern that poor outcomes will lead to financial penalties. Methods and Results—: We used Medicare data to compare change in rates of coronary artery bypass graft surgery between 2002 to 2003 and 2008 to 2009 among patients with acute myocardial infarction (AMI) admitted to 126 hospitals participating in Medicare’s Premier Hospital Quality Incentive Demonstration P4P program with patients in 848 control hospitals participating in public reporting through the Health Quality Alliance. We examined rates for all patients with AMI and those in the top decile of predicted mortality based on demographics, medical comorbidities, and AMI characteristics. We identified 91 393 patients admitted for AMI in Premier hospitals and 502 536 Medicare patients admitted for AMI in control hospitals. Coronary artery bypass graft surgery rates for patients with AMI in Premier decreased from 13.6% in 2002 to 2003 to 10.4% in 2008 to 2009; there was a comparable decrease in non-Premier hospitals (13.6%–10.6%; P value for comparison of changes between Premier and non-Premier, 0.67). Coronary artery bypass graft surgery rates for high-risk patients in Premier decreased from 8.4% in FY 2002 to 203 to 8.2% in 2008 to 2009. Patterns were similar in non-Premier hospitals (8.4%–8.3%; P value for comparison of changes between Premier and non-Premier, 0.82). Conclusions—: Our results show no evidence of a deleterious effect of P4P on access to coronary artery bypass graft surgery for high-risk patients with AMI. These results should be reassuring to those concerned about the potential negative effect of P4P on high-risk patients.


  • Open Access

    The association of hospital quality ratings with adverse events

    by Joel S. Weissman, Lenny LÓPez, Eric C. Schneider, Arnold M. Epstein, Stu Lipsitz, Saul N. Weingart

    To understand how patient-reported quality is related to adverse events (AEs). Random sample telephone survey. Sixteen acute care Massachusetts hospitals. Two thousand and five hundred and eight-two of 4163 (62% response rate) eligible adult patients. Patients hospitalized from 1 April 2003 to 1 October 2003 provided global quality ratings and whether they experienced AEs. Service recovery, defined as efforts by a service provider to return customers to a state of satisfaction after a lapse in service, was operationalized as high participation in one's care, timely discharge and disclosure of the circumstances of an AE. Of respondents, 82% rated the quality as high and 23% reported one or more AEs. Patients with no AEs gave higher quality ratings (85 vs. 77 or 62% for patients with 1 or 2+ AEs, respectively, P < 0.001). Patients were more likely to rate the quality high if they reported high participation (86 vs. 53%), or felt discharge timing was just right (85 vs. 64%); for those with AEs, ratings were higher among those reporting disclosure (82 vs. 66%) (all P < 0.01). In adjusted analyses, patients with AEs experiencing all three service recovery components rated their quality higher (86 vs. 68%, P < 0.01). Patients with AEs rate the quality of care lower than others. However, patients with AEs who experienced ‘service recovery’ as we defined it rated their quality of care at levels similar to those who did not experience AEs. Hospitals seeking to improve quality ratings might consider efforts to ensure patient safety and to address AEs in a transparent and responsive way.


  • Adverse Events Questionnaire

    by Joel S. Weissman, Lenny López, Eric C. Schneider, Arnold M. Epstein, Stu Lipsitz, Saul N. Weingart

  • Open Access

    The Relationship between Hospital Admission Rates and Rehospitalizations

    by Arnold M. Epstein, Ashish K. Jha, E. John Orav

    Efforts to reduce hospital readmissions have focused primarily on improving transitional care. Yet variation in readmission rates may more closely reflect variation in the underlying hospitalization rates than differences in the quality of care during and after discharge.